Chemo- trastuzumab combo ups survival Adjuvant therapy has feverish results in real-world careFebrile neutropenia observed at higher than expected rate Nilotinib bests imatinib in chronic myeloid leukemia Questions about tolerability and cost of treatment need answering before clinical practice should change Study OKs dose boost for estrogen receptor antagonist Statins benefit leukemia patients Clinical trials needed to pinpoint ideal candidates Study finds no difference in adjuvant therapy strategies Continuous aromatase inhibitor therapy no better than starting with tamoxifen Groups collaborate on chronic disease prevention $15.5M invested in chronic disease prevention by Canadian Partnership Against Cancer Nova Scotia, Newfoundland form breast cancer screening partnership Surviving cancer poses heart disease risk Breast imaging technique may cut unneeded biopsies First Previous 63 64 65 66 67 Next Last
